Skip to content
My WebMD Sign In, Sign Up

Melanoma/Skin Cancer Health Center

Font Size
A
A
A

New Test Helps Unmask Melanoma

continued...

Calling the research preliminary, Barbara McAlpine, MD, PhD, applauds the approach -- but with a cautionary note. McAlpine tells WebMD, "The approach they have taken is to try to identify melanoma at the point that it's under the microscope." She notes that the real window of opportunity is recognizing a mole is dangerous when examining the patient while they're in the doctor's office. McAlpine is a molecular biologist, associate professor of dermatology, and director of the Melanoma and Pigmented Lesions Center at Emory University School of Medicine in Atlanta.

Vital Information:

  • Pathologists -- doctors who test samples of body tissue for signs of disease -- may one day have a new test that helps them distinguish potentially deadly skin cancer called melanoma from tissue that only looks cancerous.
  • Developers say the test, called comparative genomic hybridization, could be most helpful in the toughest cases where even the most experienced pathologists can't determine if a tissue sample is cancerous.
  • Proponents say today's version of the test is too involved, takes too long, and costs too much to perform on a large scale. They add that in the next two years, the test can be simplified so it could be more widely available.
1 | 2

Today on WebMD

Woman checking out tan lines
SLIDESHOW
Cancer Fighting Foods Slideshow
SLIDESHOW
 
what is your cancer risk
HEALTH CHECK
Could Caffeine Help Fight Skin Cancer
VIDEO
 

12 Ways to Protect Your Skin from Melanoma
ARTICLE
precancerous lesions slideshow
SLIDESHOW
 
Do You Know Your Melanoma ABCs
VIDEO
15 Cancer Symptoms Men Ignore
ARTICLE
 

screening tests for men
SLIDESHOW
Vitamin D
SLIDESHOW
 
Is That Mole Skin Cancer
VIDEO
Brilliant sun rays
Quiz
 

WebMD Special Sections